Answers are grounded in this paper and cite their sources.
CRTH2 plays a pro-inflammatory role in TNBS-induced colitis. Eosinophils contribute to the severity of the inflammation, which is improved by a selective CRTH2 antagonist. CRTH2 may, therefore, represent an important target in the pharmacotherapy of CD.
No takes yet. Share an insight, caveat, or question.
Radnai et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: